UnknownPhase 2NCT04939116
Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
Studying Glomerular disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Angion Biomedica Corp
- Principal Investigator
- John Neylan, MDAngion Biomedica
- Intervention
- ANG-3070(drug)
- Enrollment
- 100 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2023
Study locations (29)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Amicis Reserach Center, Northridge, California, United States
- Amicis Reserach Center, Vacaville, California, United States
- South Florida Research Institute, Lauderdale Lakes, Florida, United States
- Genesis Clinical Research LLC, Tampa, Florida, United States
- Davita Clinical Research, Columbus, Georgia, United States
- The Johns Hopkins Hospital, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Davita Clinical Research, Edina, Minnesota, United States
- Clinical Research Consultants, LLC., Kansas City, Missouri, United States
- Frenova Renal Research/Nephrology and Hypertension Specialists, St Louis, Missouri, United States
- St. Louis Kidney Care, St Louis, Missouri, United States
- New Jersey Kidney Care, Jersey City, New Jersey, United States
- NYU Langone Nephrology Associates, Mineola, New York, United States
- +14 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04939116 on ClinicalTrials.govOther trials for Glomerular disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06858319Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.Novartis Pharmaceuticals
- RECRUITINGPHASE4NCT05839314Effect of Huaier Granule on the Treatment of Idiopathic Membranous NephropathyChinese PLA General Hospital
- RECRUITINGNCT05505500Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.University of Michigan
- RECRUITINGNCT04528446The Impact of Glomerular Disorders on Bone Quality and StrengthColumbia University
- RECRUITINGNCT03929887KOrea Renal Biobank NEtwoRk System TOward NExt-generation AnalysisSeoul National University Hospital
- RECRUITINGNCT02954419IgA Nephropathy Biomarkers Evaluation Study (INTEREST)Sun Yat-sen University
- RECRUITINGPHASE2NCT00977977Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)